Quercetin vs Fisetin: Which Senolytic Is Better for Longevity?

Both quercetin and fisetin are flavonoid senolytics with strong research backing. Both clear senescent cells. Both are natural compounds found in foods.

So which one should you take?

The answer comes down to potency vs. evidence base — and for most people, combining them strategically makes more sense than choosing one.

Quick Comparison

	Quercetin	Fisetin
Senolytic potency	Moderate	Very High
Human clinical trials	Yes (with dasatinib)	Yes (pilot)
Anti-inflammatory	Strong	Strong
Antioxidant	Strong	Strong
Brain health	Moderate evidence	Strong evidence
Cost	Low	Moderate
Typical dose	500–1,000mg	500–1,500mg
Best protocol	Pulse (2 days/month)	Pulse (2 days/month)

What Is Quercetin?

Quercetin is one of the most abundant flavonoids in the human diet, found in:

Capers (~233mg/100g)
Red onions (~32mg/100g)
Kale (~23mg/100g)
Apples (~4mg/100g)
Green tea (~2mg/100g)

Despite being common in food, the doses used for senolytic effects (500–1,000mg) far exceed what’s achievable through diet alone.

What Is Fisetin?

Fisetin is a related flavonoid, less abundant in food (highest in strawberries at ~0.16mg/g), but identified as the most potent natural senolytic in the landmark Mayo Clinic 2018 screening study.

Senolytic Potency: Fisetin Wins Clearly

The Mayo Clinic study that put senolytics on the map tested 10 natural compounds. Fisetin reduced senescent cell burden by ~50% — significantly outperforming quercetin and every other natural compound tested.

Quercetin showed moderate senolytic activity, but primarily in combination with the prescription drug dasatinib. As a standalone natural senolytic, quercetin is less potent than fisetin.

Winner: Fisetin

Clinical Evidence: Quercetin Has More Human Data

Here’s where quercetin pulls ahead: it has more human clinical trial data.

Quercetin + Dasatinib Human Trials

The combination of quercetin (1,000mg/day) + dasatinib (100mg/day) has been tested in:

Idiopathic pulmonary fibrosis (improved physical function)
Diabetic kidney disease (reduced senescent cell markers)
Frailty in older adults (improved physical performance)

These are significant results, but dasatinib is a prescription chemotherapy drug with its own side effects — not something you take lightly.

Quercetin Alone

Some evidence for reducing inflammation, improving metabolic markers, and cardiovascular benefits — but senolytic effects as a solo supplement are modest.

Fisetin Human Evidence

One Mayo Clinic pilot trial in older adults with kidney disease showed reduced senescent cell markers. Promising, but more limited than the quercetin+dasatinib data.

Winner: Quercetin (for quantity of human data)

Anti-Inflammatory Effects

Both are potent anti-inflammatory compounds, but through slightly different mechanisms:

Quercetin:

Inhibits NF-κB pathway
Reduces histamine (antihistamine effects)
Inhibits COX-2 and lipoxygenase enzymes

Fisetin:

Inhibits NF-κB
Reduces SASP (senescence-associated secretory phenotype)
Reduces IL-6, TNF-α, and other inflammatory cytokines

For general anti-inflammatory use, quercetin has more evidence. For specifically targeting age-related inflammation (driven by senescent cells), fisetin may be more targeted.

Brain Health: Fisetin Wins

Fisetin has surprisingly strong preclinical evidence for neuroprotection:

Old mice treated with fisetin maintained cognitive function comparable to young mice (Aging Cell, 2018)
Reduces amyloid-beta toxicity in Alzheimer’s models
Promotes BDNF and nerve growth factor
Clinical trial for Alzheimer’s currently ongoing (MCLENA-1 trial)

Quercetin has some cognitive benefits but less compelling data than fisetin.

Winner: Fisetin

Bioavailability: Both Are Challenging

Neither compound absorbs well from standard supplement forms.

Quercetin solutions:

Quercetin phytosome (Quercefit™) — ~20x better absorption
Quercetin dihydrate — better than aglycone form
Take with fat and black pepper (piperine)

Fisetin solutions:

Liposomal fisetin — significantly improved absorption
Take with fatty meal
Some evidence piperine helps

Dosage Protocols

Quercetin Protocol

For senolytic effects:

500–1,000mg/day for 2 consecutive days/month
Stack with fisetin for synergistic effects
Take with food and fat

For general anti-inflammatory use:

500mg/day daily
Quercetin phytosome form preferred

Fisetin Protocol

For senolytic effects:

1,000–1,500mg/day for 2 consecutive days/month
Liposomal form preferred
Take with fat

The Case for Combining Both

Here’s why many longevity researchers and biohackers use both:

Different mechanisms — they target slightly different pathways
Potential synergy — combining may clear more senescent cell subtypes
Both have independent benefits beyond senolytics (anti-inflammatory, antioxidant, neuroprotective)
Low risk — both have excellent safety profiles

Popular combined protocol:

Day 1 & 2 each month: Fisetin 1,000mg + Quercetin 500mg
Daily: Quercetin 250–500mg for anti-inflammatory benefits

Safety Comparison

Both are well-tolerated with good safety profiles.

Quercetin concerns:

Possible kidney toxicity at very high doses (>1g/day long-term) — theoretical
May inhibit thyroid hormone synthesis at high doses
Drug interactions: blood thinners, antibiotics (quinolones), cyclosporine

Fisetin concerns:

Mild anticoagulant activity — caution with blood thinners
Weak estrogenic activity — consult physician if on hormone therapy
Pregnancy: avoid both

Who Should Choose What

Choose quercetin if you:

Want well-studied anti-inflammatory effects
Have allergies (quercetin has antihistamine properties)
Are focused on cardiovascular health
Want a lower-cost option

Choose fisetin if you:

Prioritize maximum senolytic potency
Are focused on brain health and cognitive longevity
Are willing to pay more for a more targeted effect

Use both if you:

Are serious about longevity optimization
Are 50+ and actively targeting biological aging
Track biomarkers and want comprehensive coverage

The Bottom Line

Fisetin is the more potent senolytic. If you can only take one, and senolytic activity is your primary goal, fisetin wins.

Quercetin has more diverse human evidence and excellent anti-inflammatory benefits that stand independently of its senolytic effects.

The optimal approach is likely combining both in a monthly pulse protocol, with optional daily low-dose quercetin for ongoing anti-inflammatory support.